Artwork

Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Price of Drugs: Investing amid pharma's politics

19:26
 
Share
 

Manage episode 177834526 series 124416
Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians.In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

997 episodes

Artwork
iconShare
 
Manage episode 177834526 series 124416
Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians.In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

997 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide